Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03140709 · ClinicalTrials.gov registry record
Non-Invasive, Highly Specific Detection of Oxytocin in Biological Fluids
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 28
- Enrollment target
NCT03140709: Completed study, sponsored by Stanford University.
NCT03140709 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 28 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03140709 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 28 participants
- Enrollment target
Study Summary
This study will aid in the development of a research instrument for rapid and highly sensitive detection of perinatal salivary oxytocin, by non-invasive means. There will be two study cohorts: Induction of labor cohort (20) and Cesarean delivery cohort (5) for a total of 25 participants.The standard clinical protocols for administering oxytocin to human subjects at Lucile Packard Children's Hospital will be followed. Oxytocin will be prescribed and dosed as per standard of care with no change due to study enrollment. The study will only involve sampling of saliva and blood. The general hypothesis to be tested is that 1) the sensor will accurately report the levels of oxytocin in saliva samples as compared with standard reference methods and 2) the sensor yields rapid (\<20 minutes) oxytocin results with minimal discomfort to subjects. Overall, this will allow to optimize the administration of oxytocin, and for a better understanding of the blood concentration and effects of oxytocin on mother and child.
Interventions
- DRUG Oxytocin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2016-05 |
| Est. Completion | 2016-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03140709
The ClinicalTrials.gov registry entry for NCT03140709 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Oxytocin is the first listed.
NCT03140709 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03140709 about?
NCT03140709 is a clinical study titled "Non-Invasive, Highly Specific Detection of Oxytocin in Biological Fluids". This study will aid in the development of a research instrument for rapid and highly sensitive detection of perinatal salivary oxytocin, by non-invasive means. There will be two study cohorts: Induction of labor cohort (20) and Cesarean delivery cohort (5) for a total of 25 participants.The standard...
What is the current status of trial NCT03140709?
This trial is currently completed. The enrollment target is 28 participants. The study started on 2016-05. Estimated completion is 2016-07.
What interventions are being tested in trial NCT03140709?
The interventions under investigation include: Oxytocin (DRUG).
Who is sponsoring clinical trial NCT03140709?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.